Results 261 to 270 of about 331,457 (367)
When biliary-gastric fistula mimics double gallbladder: a diagnostic challenge in acute cholecystitis. [PDF]
El Bouazizi Y+9 more
europepmc +1 more source
Abstract Objective Our objective was to evaluate how the incidence of cancer after metabolic and bariatric surgery (MBS) compared with the general population. Methods A nationwide cohort of patients who underwent MBS in Sweden from 2007 to 2020 were matched (age, sex, area of residence) to controls from the general population.
Erik Stenberg+4 more
wiley +1 more source
Cytomegalovirus reactivation in autoimmune liver diseases. Can we diagnose it earlier?: A case report. [PDF]
Filho RCS+5 more
europepmc +1 more source
Development of Deferoxamine‐Functionalized Cyclodextrin Polymer for Targeted Iron Chelation
The cyclodextrin polymer is conjugated with 35 deferoxamine units and can form iron(III) complexes. The polymer exhibits significantly lower antiproliferative activity than free deferoxamine. The cyclodextrin polymer with multiple deferoxamine units may present a promising strategy for improving the efficacy of iron chelation therapies.
Roberta Panebianco+2 more
wiley +1 more source
Proposal for a New Classification of Rare Cancers Adopting Updated Histological Tumor Types. [PDF]
Rikitake R+8 more
europepmc +1 more source
The Ultrasonography Characteristics of Borderline Ovarian Tumor Subtypes
Journal of Ultrasound in Medicine, EarlyView.
Roni Yoeli‐Bik+6 more
wiley +1 more source
This systematic review synthesizes decade‐long evidence from peer‐reviewed literature and clinical guidelines, critically evaluating current understanding of OARs tolerance in proton therapy. Abstract Proton beam therapy has demonstrated significant clinical efficacy across multiple malignancies, primarily attributed to its distinct physical dose ...
Jinghao Duan+10 more
wiley +1 more source
Comparison of prognostic factors and their differences in intrahepatic, hilar, and distal cholangiocarcinoma: A systematic review and meta-analysis. [PDF]
Hussain MM+4 more
europepmc +1 more source
ABSTRACT Linerixibat, an ileal bile acid transporter (IBAT) inhibitor, is being evaluated for the treatment of pruritus in primary biliary cholangitis (PBC). Diarrhea is commonly reported with this drug class as IBAT inhibition redirects bile acids (BA) to the colon.
Fernando Carreño+4 more
wiley +1 more source